Why are there not more projects involving patients? In our very first episode, Enrico Mastroianni from Novo Nordisk and Simon O’Neill from our Patient Advisory Committee (PAC) talk about the challenges and, of course, the many benefits of involving people with diabetes as equal partners in huge research consortia, such as Hypo-RESOLVE.

Subscribe to the show so you will never miss an episode. Be sure to catch our next episode, when we are trying to make sense of the effects and consequences of hypoglycaemia and tell you more about our work within the Hypo-RESOLVE project. Thanks for listening!